SCHEMBL4314650

SCHEMBL4314650

Cc1ncc(Cl)c(-c2cccs2)c1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.43
ALDH1A1 P00352 5/20 0.43
GAA P10253 3/20 0.43
MAPT P10636 3/20 0.43
TSHR P16473 2/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CHEK1 O14757 1/20 0.38
CHEK2 O96017 1/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
RET P07949 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
IKBKB O14920 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4341035 0.86 KDM4E (0.44) KDM4EALDH1A1GAAMAPTTSHR
SCHEMBL30174200 0.78 KDM4E (0.51) KDM4EALDH1A1GAAMAPTTSHR
SCHEMBL30174203 0.76 ERCC1 (0.46) KDM4EALDH1A1GAAMAPTTSHR
SCHEMBL28966254 0.74 NEK2 (0.43) KDM4EALDH1A1GAAMAPTTSHR
SCHEMBL2454771 0.70 KMT2A (0.41) KDM4EALDH1A1GAAMAPTTSHR
SCHEMBL2454769 0.70 KMT2A (0.41) KDM4EALDH1A1GAAMAPTTSHR
SCHEMBL6532745 0.70 CCNE2 (0.41) KDM4EALDH1A1GAAMAPTTSHR
SCHEMBL30174190 0.69 AR (0.56) KDM4EALDH1A1GAAMAPTTSHR
SCHEMBL7439553 0.69 ERCC1 (0.44) KDM4EALDH1A1GAAMAPTTSHR
SCHEMBL4314653 0.68 KDM4E (0.47) KDM4EALDH1A1GAAMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084470-B2 Substituted nicotinamide compounds and uses thereof GRUENENTHAL GMBH (DE) 2011-12-27 US disclosed
US-20090076086-A1 SUBSTITUTED NICOTINAMIDE COMPOUNDS AND USES THEREOF GRUENENTHAL GMBH (DE) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076086-A1 SUBSTITUTED NICOTINAMIDE COMPOUNDS AND USES THEREOF NNT, NAMPT, NADK KDM4E 2156/4885ALDH1A1 281/4885GAA 1201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.